Evidence map›Paper›PMID 33608328›Full record

ArticleDiabetes care2021

Comment on Herring et al. Metabolic Effects of an SGLT2 Inhibitor (Dapagliflozin) During a Period of Acute Insulin Withdrawal and Development of Ketoacidosis in People With Type 1 Diabetes. Diabetes Care 2020;43:2128-2136.

Geremia B Bolli, Francesca Porcellati, Paola Lucidi, Carmine G Fanelli

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Diabetes care, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.5field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Trial
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Geremia B BolliSection of Endocrinology and Metabolism, Department of Medicine, University of Perugia Medical School, Perugia, Italy bolli@unipg.it.ORCID 0000-0003-4966-4003
Francesca PorcellatiSection of Endocrinology and Metabolism, Department of Medicine, University of Perugia Medical School, Perugia, Italy.
Paola LucidiSection of Endocrinology and Metabolism, Department of Medicine, University of Perugia Medical School, Perugia, Italy.
Carmine G FanelliSection of Endocrinology and Metabolism, Department of Medicine, University of Perugia Medical School, Perugia, Italy.
University of Perugia · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Diabetes Mellitus, Type 1KetosisSodium-Glucose Transporter 2 InhibitorsBenzhydryl CompoundsGlucosidesHumansInsulinBenzhydryl CompoundsdapagliflozinGlucosidesInsulinSodium-Glucose Transporter 2 Inhibitors

Identifiers

PMID33608328
OpenAlexW3131875595

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.